Skip to main content
Toggle navigation
Login
Search
Home
Full Schedule
Home
Full Schedule
All Days
Fri, Mar 31
Sat, Apr 1
Thu, Apr 20
Fri, Apr 21
Fri, May 19
Sat, May 20
Thu, Jun 15
Fri, Jun 16
Fri, Jul 21
Sat, Jul 22
Thu, Aug 17
Fri, Aug 18
Thu, Sep 14
Fri, Sep 15
Full Schedule
Type here to filter the list
Thursday, April 20, 2023
12:00 PM – 12:15 PM
.
Welcome
12:00 PM – 12:15 PM
.
Welcome
12:15 PM – 1:00 PM
.
Session I: 2023 Updates in IBD Management
Speaker:
Millie D. Long, MD, MPH, FACG
– University of North Carolina at Chapel Hill
Speaker:
Florian Rieder, MD
– Cleveland Clinic
12:15 PM – 1:00 PM
.
Session I: 2023 Updates in IBD Management
Speaker:
Millie D. Long, MD, MPH, FACG
– University of North Carolina at Chapel Hill
Speaker:
Florian Rieder, MD
– Cleveland Clinic
12:15 PM – 12:35 PM
.
Update on the Management of UC
Speaker:
Millie D. Long, MD, MPH, FACG
– University of North Carolina at Chapel Hill
12:35 PM – 12:55 PM
.
Stricturing Crohn's Disease
Speaker:
Florian Rieder, MD
– Cleveland Clinic
12:55 PM – 1:00 PM
.
Q&A Panel
1:15 PM – 2:15 PM
.
Non-CME Innovation Theater
1:15 PM – 2:15 PM
.
Non-CME Innovation Theater
2:30 PM – 3:15 PM
.
Session II: Advances in Fistulizing Crohn’s Disease: Emerging Therapies and Patient-Centric Management Strategies
Speaker:
Stefan D. Holubar, MD, MS, FACS, FASCRS (he/him/his)
– Cleveland Clinic
2:30 PM – 3:15 PM
.
Session II: Advances in Fistulizing Crohn’s Disease: Emerging Therapies and Patient-Centric Management Strategies
Speaker:
Stefan D. Holubar, MD, MS, FACS, FASCRS (he/him/his)
– Cleveland Clinic
2:30 PM – 3:00 PM
.
Advances in Fistulizing Crohn’s Disease: Emerging Therapies and Patient-Centric Management Strategies
Speaker:
Stefan D. Holubar, MD, MS, FACS, FASCRS (he/him/his)
– Cleveland Clinic
3:00 PM – 3:15 PM
.
Q&A Panel
3:30 PM – 4:30 PM
.
Non-CME Innovation Theater
3:30 PM – 4:30 PM
.
Non-CME Innovation Theater
4:45 PM – 5:30 PM
.
Session III: Strategies to Address Barriers and Optimize Outcomes in Luminal Crohn’s Disease
Speaker:
Florian Rieder, MD
– Cleveland Clinic
4:45 PM – 5:30 PM
.
Session III: Strategies to Address Barriers and Optimize Outcomes in Luminal Crohn’s Disease
Speaker:
Florian Rieder, MD
– Cleveland Clinic
4:45 PM – 5:15 PM
.
Strategies to Address Barriers and Optimize Outcomes in Luminal Crohn’s Disease
Speaker:
Florian Rieder, MD
– Cleveland Clinic
5:15 PM – 5:30 PM
.
Q&A Panel
Friday, April 21, 2023
8:00 AM – 8:15 AM
.
Welcome
8:00 AM – 8:15 AM
.
Welcome
8:15 AM – 9:00 AM
.
Session IV: Special Situations in UC
Speaker:
Raymond K. Cross, Jr., MD, MS, AGAF, FACG
– University of Maryland School of Medicine
Speaker:
David T. Rubin, MD, FACG (he/him/his)
– University of Chicago Medicine
8:15 AM – 9:00 AM
.
Session IV: Special Situations in UC
Speaker:
Raymond K. Cross, Jr., MD, MS, AGAF, FACG
– University of Maryland School of Medicine
Speaker:
David T. Rubin, MD, FACG (he/him/his)
– University of Chicago Medicine
8:15 AM – 8:30 AM
.
Management of Hospitalized UC Patient
Speaker:
Raymond K. Cross, Jr., MD, MS, AGAF, FACG
– University of Maryland School of Medicine
8:30 AM – 8:45 AM
.
Dysplasia in IBD: Best Practices
Speaker:
David T. Rubin, MD, FACG (he/him/his)
– University of Chicago Medicine
8:45 AM – 9:00 AM
.
Q&A Panel
Moderator:
Millie D. Long, MD, MPH, FACG
– University of North Carolina at Chapel Hill
Panelist:
Raymond K. Cross, Jr., MD, MS, AGAF, FACG
– University of Maryland School of Medicine
Panelist:
Stefan D. Holubar, MD, MS, FACS, FASCRS (he/him/his)
– Cleveland Clinic
Panelist:
David T. Rubin, MD, FACG (he/him/his)
– University of Chicago Medicine
9:15 AM – 10:00 AM
.
Session V: Optimized Care for Patients With IBD: The Potential Benefits of Interleukin Inhibitors
Speaker:
Gil Y. Melmed, MD, MS, FACG, AGAF
– Cedars-Sinai Medical Center
9:15 AM – 10:00 AM
.
Session V: Optimized Care for Patients With IBD: The Potential Benefits of Interleukin Inhibitors
Speaker:
Gil Y. Melmed, MD, MS, FACG, AGAF
– Cedars-Sinai Medical Center
9:15 AM – 9:45 AM
.
Optimized Care for Patients With IBD: The Potential Benefits of Interleukin Inhibitors
Speaker:
Gil Y. Melmed, MD, MS, FACG, AGAF
– Cedars-Sinai Medical Center
9:45 AM – 10:00 AM
.
Q&A Panel
10:15 AM – 11:15 AM
.
Non-CME Innovation Theater
10:15 AM – 11:15 AM
.
Non-CME Innovation Theater
11:30 AM – 12:15 PM
.
Session VI: Optimizing Existing Therapies in the Management of IBD
Speaker:
Jessica R. Allegretti, MD,MPH, FACG, AGAF
– Brigham and Women's Hospital, Harvard Medical School
11:30 AM – 12:15 PM
.
Session VI: Optimizing Existing Therapies in the Management of IBD
Speaker:
Jessica R. Allegretti, MD,MPH, FACG, AGAF
– Brigham and Women's Hospital, Harvard Medical School
11:30 AM – 12:00 PM
.
Optimizing Existing Therapies in the Management of IBD
Speaker:
Jessica R. Allegretti, MD,MPH, FACG, AGAF
– Brigham and Women's Hospital, Harvard Medical School
12:00 PM – 12:15 PM
.
Q&A Panel
12:30 PM – 1:15 PM
.
Session VII: Utilizing our Therapeutic Armamentarium: Right Patient/Right Drug
Speaker:
David T. Rubin, MD, FACG (he/him/his)
– University of Chicago Medicine
Speaker:
Florian Rieder, MD
– Cleveland Clinic
12:30 PM – 1:15 PM
.
Session VII: Utilizing our Therapeutic Armamentarium: Right Patient/Right Drug
Speaker:
David T. Rubin, MD, FACG (he/him/his)
– University of Chicago Medicine
Speaker:
Florian Rieder, MD
– Cleveland Clinic
12:30 PM – 12:45 PM
.
JAK Inhibitors: Efficacy and Safety
Speaker:
David T. Rubin, MD, FACG (he/him/his)
– University of Chicago Medicine
12:45 PM – 1:00 PM
.
Role of Anti-TNF and Anti-Integrin in IBD
Speaker:
Florian Rieder, MD
– Cleveland Clinic
1:00 PM – 1:15 PM
.
Q&A Panel
1:30 PM – 2:30 PM
.
Non-CME Innovation Theater
1:30 PM – 2:30 PM
.
Non-CME Innovation Theater
2:45 PM – 3:30 PM
.
Session VIII: Harnessing the Utility of Selective Sphingosine 1-Phosphate Receptor Modulators to Optimize Patient Care in IBD
Speaker:
Raymond K. Cross, Jr., MD, MS, AGAF, FACG
– University of Maryland School of Medicine
2:45 PM – 3:30 PM
.
Session VIII: Harnessing the Utility of Selective Sphingosine 1-Phosphate Receptor Modulators to Optimize Patient Care in IBD
Speaker:
Raymond K. Cross, Jr., MD, MS, AGAF, FACG
– University of Maryland School of Medicine
2:45 PM – 3:15 PM
.
Harnessing the Utility of Selective Sphingosine 1-Phosphate Receptor Modulators to Optimize Patient Care in IBD
Speaker:
Raymond K. Cross, Jr., MD, MS, AGAF, FACG
– University of Maryland School of Medicine
3:15 PM – 3:30 PM
.
Q&A Panel
3:45 PM – 4:30 PM
.
Session IX: Increasing Access to Improve Outcomes: Exploring the Role of Biosimilars in the Management of Inflammatory Bowel Disease
Speaker:
Christina Y. Ha, MD, FACG, AGAF
– Mayo Clinic Scottsdale
3:45 PM – 4:30 PM
.
Session IX: Increasing Access to Improve Outcomes: Exploring the Role of Biosimilars in the Management of Inflammatory Bowel Disease
Speaker:
Christina Y. Ha, MD, FACG, AGAF
– Mayo Clinic Scottsdale
3:45 PM – 4:15 PM
.
Increasing Access to Improve Outcomes: Exploring the Role of Biosimilars in the Management of Inflammatory Bowel Disease
Speaker:
Christina Y. Ha, MD, FACG, AGAF
– Mayo Clinic Scottsdale
4:15 PM – 4:30 PM
.
Q&A Panel
4:45 PM – 5:30 PM
.
Session X: Putting Your Knowledge to the Test: Challenging IBD cases
Speaker:
Gil Y. Melmed, MD, MS, FACG, AGAF
– Cedars-Sinai Medical Center
Panelist:
Millie D. Long, MD, MPH, FACG
– University of North Carolina at Chapel Hill
Panelist:
Florian Rieder, MD
– Cleveland Clinic
Panelist:
Christina Y. Ha, MD, FACG, AGAF
– Mayo Clinic Scottsdale
4:45 PM – 5:30 PM
.
Session X: Putting Your Knowledge to the Test: Challenging IBD cases
Speaker:
Gil Y. Melmed, MD, MS, FACG, AGAF
– Cedars-Sinai Medical Center
Panelist:
Millie D. Long, MD, MPH, FACG
– University of North Carolina at Chapel Hill
Panelist:
Florian Rieder, MD
– Cleveland Clinic
Panelist:
Christina Y. Ha, MD, FACG, AGAF
– Mayo Clinic Scottsdale
4:45 PM – 5:30 PM
.
Case Panel
Panelist:
Christina Y. Ha, MD, FACG, AGAF
– Mayo Clinic Scottsdale
Panelist:
Florian Rieder, MD
– Cleveland Clinic
Panelist:
Millie D. Long, MD, MPH, FACG
– University of North Carolina at Chapel Hill
Moderator:
Gil Y. Melmed, MD, MS, FACG, AGAF
– Cedars-Sinai Medical Center
